Financials
- Market Capitalization 1.84 B
- Employee 835
- Founded 1980
- CEO Douglas S. Ingram
- Website www.sarepta.com
- Headquarter Delaware, United States
- FIGI BBG000BCJ161
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-3.02
Fiyat/satışlar oranı
0.98
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 2000 | MESO Mesoblast Limited - American Depositary Shares | 14.27 USD | -0.14% | +2.66% | -5.93% | -19.79% | 1.85 B USD | ||
| 2005 | TRVI Trevi Therapeutics, Inc. - Common Stock | 12.93 USD | -1.97% | -6.51% | -19.19% | +35.39% | 1.84 B USD | ||
| 2007 | AGIO Agios Pharmaceuticals, Inc. - Common Stock | 30.82 USD | -3.11% | -2.13% | -8.90% | -28.97% | 1.84 B USD | ||
| 2011 | MRVI Maravai LifeSciences Holdings, Inc. - Class A common stock | 7.06 USD | -5.11% | -17.33% | +8.12% | +119.94% | 1.83 B USD |